These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15247126)

  • 1. Mammographic density in relation to daidzein-metabolizing phenotypes in overweight, postmenopausal women.
    Frankenfeld CL; McTiernan A; Aiello EJ; Thomas WK; LaCroix K; Schramm J; Schwartz SM; Holt VL; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1156-62. PubMed ID: 15247126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Thomas WK; LaCroix K; McVarish L; Holt VL; Schwartz SM; Lampe JW
    Maturitas; 2006 Feb; 53(3):315-24. PubMed ID: 16019168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daidzein-metabolizing phenotypes in relation to mammographic breast density among premenopausal women in the United States.
    Atkinson C; Newton KM; Aiello Bowles EJ; Lehman CD; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
    Breast Cancer Res Treat; 2009 Aug; 116(3):587-94. PubMed ID: 18821061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum steroid hormones, sex hormone-binding globulin concentrations, and urinary hydroxylated estrogen metabolites in post-menopausal women in relation to daidzein-metabolizing phenotypes.
    Frankenfeld CL; McTiernan A; Tworoger SS; Atkinson C; Thomas WK; Stanczyk FZ; Marcovina SM; Weigle DS; Weiss NS; Holt VL; Schwartz SM; Lampe JW
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):399-408. PubMed ID: 15145450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equol status modifies the association of soy intake and mammographic density in a sample of postmenopausal women.
    Fuhrman BJ; Teter BE; Barba M; Byrne C; Cavalleri A; Grant BJ; Horvath PJ; Morelli D; Venturelli E; Muti PC
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):33-42. PubMed ID: 18199709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.
    Frankenfeld CL; Atkinson C; Thomas WK; Gonzalez A; Jokela T; Wähälä K; Schwartz SM; Li SS; Lampe JW
    Br J Nutr; 2005 Dec; 94(6):873-6. PubMed ID: 16351761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States.
    Atkinson C; Newton KM; Bowles EJ; Yong M; Lampe JW
    Am J Clin Nutr; 2008 Mar; 87(3):679-87. PubMed ID: 18326607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to O-desmethylangolensin in peri- and post-menopausal women.
    Miller LM; Lampe JW; Newton KM; Gundersen G; Fuller S; Reed SD; Frankenfeld CL
    Maturitas; 2017 May; 99():37-42. PubMed ID: 28364866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risks in relation to daidzein metabolizing phenotypes among Chinese postmenopausal women.
    Liu ZM; Ho SC; Chen YM; Liu J; Woo J
    PLoS One; 2014; 9(2):e87861. PubMed ID: 24533060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity prevalence in relation to gut microbial environments capable of producing equol or O-desmethylangolensin from the isoflavone daidzein.
    Frankenfeld CL; Atkinson C; Wähälä K; Lampe JW
    Eur J Clin Nutr; 2014 Apr; 68(4):526-30. PubMed ID: 24569543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daidzein-metabolizing phenotypes in relation to serum hormones and sex hormone binding globulin, and urinary estrogen metabolites in premenopausal women in the United States.
    Atkinson C; Newton KM; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
    Cancer Causes Control; 2008 Dec; 19(10):1085-93. PubMed ID: 18478336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China.
    Guo K; Zhang B; Chen C; Uchiyama S; Ueno T; Chen Y; Su Y
    Br J Nutr; 2010 Jul; 104(1):118-24. PubMed ID: 20205965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term fructooligosaccharide intake on equol production in Japanese postmenopausal women consuming soy isoflavone supplements: a pilot study.
    Tousen Y; Uehara M; Abe F; Kimira Y; Ishimi Y
    Nutr J; 2013 Sep; 12():127. PubMed ID: 24034304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daidzein-metabolizing phenotypes in relation to bone density and body composition among premenopausal women in the United States.
    Atkinson C; Newton KM; Yong M; Stanczyk FZ; Westerlind KC; Li L; Lampe JW
    Metabolism; 2012 Dec; 61(12):1678-82. PubMed ID: 22819530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of urinary isoflavones and lignan polyphenols in Japanese women.
    Liu W; Tanabe M; Harada KH; Koizumi A
    Environ Health Prev Med; 2013 Sep; 18(5):394-400. PubMed ID: 23632985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora.
    Rowland IR; Wiseman H; Sanders TA; Adlercreutz H; Bowey EA
    Nutr Cancer; 2000; 36(1):27-32. PubMed ID: 10798213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differences in equol production capability modulate blood pressure in tibolone-treated postmenopausal women: lack of effect of soy supplementation.
    Törmälä RM; Appt S; Clarkson TB; Tikkanen MJ; Ylikorkala O; Mikkola TS
    Climacteric; 2007 Dec; 10(6):471-9. PubMed ID: 18049940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-desmethylangolensin: the importance of equol's lesser known cousin to human health.
    Frankenfeld CL
    Adv Nutr; 2011 Jul; 2(4):317-24. PubMed ID: 22332073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.